Principal Investigator
Silvia Delgado
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20240256
Clinical Trial Summary
An interventional, Phase 3 extension study to investigate long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary progressive multiple sclerosis, or nonrelapsing secondary progressive multiple sclerosis
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Multiple Sclerosis
Contact Information
Study Contact
Gloria Rodriguez
Phone Number
+1 (305) 2438052
Email
g.rodriguez8@miami.edu